To accelerate the development of novel fungicides, a variety of -(pyrazol-5-yl)benzamide derivatives with a diphenylamine moiety were designed and synthesized using a pharmacophore recombination strategy based on the structure of pyrazol-5-yl-aminophenyl-benzamides. The bioassay results demonstrated that most of the target compounds had excellent antifungal activities against , , and . In particular, compound exhibited remarkable activity against (EC = 0.37 mg/L), which was similar to that of fluxapyroxad (EC = 0.27 mg/L). In addition, compound (EC = 1.32 mg/L) was observed to be more effective against than fluxapyroxad (EC = 12.8 mg/L) and comparable to trifloxystrobin (EC = 1.62 mg/L). Furthermore, compound demonstrated remarkable protective antifungal properties against , with an inhibition rate of 96.8% at 100 mg/L, which was close to that of fluxapyroxad (99.6%). Compounds (66.7%) and (62.9%) exhibited good antifungal effects against at 100 mg/L, which were superior to that of fluxapyroxad (11.1%) but lower than that of trifloxystrobin (88.9%). The succinate dehydrogenase (SDH) enzymatic inhibition assay was conducted to confirm the mechanism of action. Molecular docking analysis further revealed that compound has significant hydrogen-bonding, π-π, and p-π conjugation interactions with ARG 43, SER 39, TRP 173, and TYR 58 in the binding site of SDH, and the binding mode was similar to that of the commercial fungicide fluxapyroxad. All of the results suggest that compound could be a potential SDH inhibitor, offering a valuable reference for future studies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acs.jafc.3c07567 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!